HALIFAX, NS / ACCESSWIRE / / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended ...
GlobalData on MSN10d
Health Canada approves MedMira’s rapid test for HIV and syphilisThe test enables healthcare professionals to identify HIV-1/2 and syphilis antibodies from a single finger prick sample.
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ...
During Q1 FY2025, MedMira has been continuing its regulatory work and clinical trials for its Reveal® G4 HIV-1/2 rapid test CLIA-waiver and with it made substantial progress on its FDA ...
Medmira (TSE:MIR) has released an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall Street analysts, ...
12d
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, ...
all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter MedMira Inc. has reported significant progress in its regulatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback